Twenty One Capital (XXI) CEO and director receive 6.09M stock options
Rhea-AI Filing Summary
Twenty One Capital, Inc.'s chief executive officer, who is also a director, received a grant of 6,089,634 stock options on December 8, 2025 at an exercise price of $14.43 per share. These options relate to Class A common stock and were granted at no cost to the reporting person and are held directly. The options expire on December 8, 2035. According to the vesting schedule, 20% of the options will vest on April 1, 2026, and the remaining 80% will vest quarterly in equal tranches over the following four years.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Twenty One Capital (XXI) disclose in this Form 4?
The company reported that its chief executive officer and director acquired 6,089,634 stock options on December 8, 2025, covering Class A common stock.
What is the exercise price and term of the new Twenty One Capital (XXI) stock options?
The stock options have an exercise price of $14.43 per share and an expiration date of December 8, 2035, giving the holder the right to buy Class A common stock until that date.
How do the Twenty One Capital (XXI) CEO stock options vest?
The options vest in two stages: 20% vest on April 1, 2026, and the remaining 80% vest quarterly in equal tranches over the subsequent four years.
How many derivative securities does the reporting person hold after this Form 4 transaction for XXI?
Following the reported transaction, the reporting person beneficially owns 6,089,634 derivative securities
What class of stock underlies the new stock options at Twenty One Capital (XXI)?
The stock options are exercisable into Class A common stock of Twenty One Capital, Inc., with 6,089,634 shares underlying the options.
Is this Form 4 for a single insider at Twenty One Capital (XXI)?
Yes. The disclosure states that the Form is filed by one reporting person, who serves as both chief executive officer and director of the company.